UOC

UBS O'Connor Portfolio holdings

AUM $3.76B Turnover 54.76%
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.22B
AUM Growth
-$1.2B
Cap. Flow
-$1.32B
Cap. Flow %
-31.23%
Top 10 Hldgs %
40.53%
Holding
893
New
143
Increased
129
Reduced
82
Closed
273
Avg Time Held Equity + Options
0.9 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.2 years

Top Buys

Rank Stock Value
1
OSH
Oak Street Health, Inc.
OSH
+$211M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$189M
3
UNVR
Univar Solutions Inc.
UNVR
+$175M
4
MAXR
Maxar Technologies Inc. Common Stock
MAXR
+$143M
5
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$137M

Top Sells

Rank Stock Value
1
STOR
STORE Capital Corporation
STOR
+$414M
2
LHCG
LHC Group LLC
LHCG
+$211M
3
ATVI
Activision Blizzard
ATVI
+$196M
4
SGFY
Signify Health, Inc.
SGFY
+$161M
5
ONEM
1Life Healthcare
ONEM
+$141M

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.3%
3 Technology 18.64%
4 Miscellaneous 15.12%
5 Industrials 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
META icon
451
Meta Platforms (Facebook)
META
$1.88T
$424K 0.01%
+2,000
New +$341K
2023 Q1
0 quarters
FNA icon
452
DELISTED
Paragon 28, Inc.
FNA
$423K 0.01%
+24,800
New +$442K
2023 Q1
0 quarters
PRAX icon
453
Praxis Precision Medicines
PRAX
$6.67B
$410K 0.01%
33,817
+24,651
+269% +$1.04M
2022 Q1
4 quarters
M icon
454
PUT
Macy's
M
$5.92B
$410K 0.01%
112,500
-52,000
-32% -$1.1M
2021 Q2
7 quarters
CHGG icon
455
Chegg
CHGG
$77.8M
$408K 0.01%
+25,000
New +$468K
2023 Q1
0 quarters
TDC icon
456
Teradata
TDC
$2.78B
$403K 0.01%
+10,003
New +$372K
2023 Q1
0 quarters
SYBX icon
457
DELISTED
Synlogic
SYBX
$402K 0.01%
42,354
– –
2022 Q1
4 quarters
ELAN icon
458
Elanco Animal Health
ELAN
$11.3B
$395K 0.01%
42,000
+2,000
+5% +$23.6K
2022 Q4
1 quarter
PRQR icon
459
ProQR Therapeutics
PRQR
$207M
$383K 0.01%
+180,000
New +$550K
2023 Q1
0 quarters
DASH icon
460
DoorDash
DASH
$79.7B
$381K 0.01%
+6,000
New +$344K
2023 Q1
0 quarters
XLF icon
461
PUT
State Street Financial Select Sector SPDR ETF
XLF
$50.7B
$381K 0.01%
+750,000
New +$26.1M
2023 Q1
0 quarters
EIGR
462
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$379K 0.01%
14,070
-1,667
-11% -$77.5K
2022 Q1
4 quarters
DAWN icon
463
DELISTED
Day One Biopharmaceuticals
DAWN
$375K 0.01%
28,053
-15,883
-36% -$310K
2022 Q3
2 quarters
CTMX icon
464
CytomX Therapeutics
CTMX
$486M
$373K 0.01%
247,157
+51,769
+26% +$117K
2022 Q4
1 quarter
CABA icon
465
Cabaletta Bio
CABA
$275M
$372K 0.01%
+45,000
New +$421K
2023 Q1
0 quarters
EVLVW icon
466
DELISTED
Evolv Technologies Warrant
EVLVW
$372K 0.01%
708,885
– –
2021 Q3
6 quarters
SYK icon
467
Stryker
SYK
$108B
$366K 0.01%
1,283
-2,939
-70% -$780K
2022 Q2
3 quarters
ORTX
468
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$363K 0.01%
67,512
+24,214
+56% +$132K
2022 Q1
4 quarters
NFLX icon
469
Netflix
NFLX
$294B
$357K 0.01%
+10,330
New +$342K
2023 Q1
0 quarters
CYPH icon
470
Cypherpunk Technologies Inc
CYPH
$282M
$357K 0.01%
+104,869
New +$550K
2023 Q1
0 quarters
UBX icon
471
DELISTED
Unity Biotechnology
UBX
$347K 0.01%
213,040
– –
2022 Q3
2 quarters
ESPR icon
472
DELISTED
Esperion Therapeutics
ESPR
$328K 0.01%
206,259
+114,822
+126% +$593K
2022 Q3
2 quarters
RVLP
473
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$315K 0.01%
276,428
– –
2022 Q3
2 quarters
AKTS icon
474
DELISTED
Akoustis Technologies Inc
AKTS
$308K 0.01%
100,000
– –
2022 Q4
1 quarter
CPRI icon
475
PUT
Capri Holdings
CPRI
$1.71B
$307K 0.01%
18,200
-3,100
-15% -$166K
2021 Q2
7 quarters
17 18
19
20 21

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return
JCM
Janney Capital Management Pittsburgh, Pennsylvania $1.59B AUM 23.25% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 893 positions worth $4.22B, down 22% from $5.42B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.32B in Q1 2023, closing 273 positions and reducing 82 holdings. Its most notable exit was STORE Capital Corporation, an estimated $414M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, UBS O'Connor opened a new position in Oak Street Health, Inc. worth $25.3M.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited STORE Capital Corporation in Q1 2023, selling an estimated $414M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 143 new positions and closed 273 in Q1 2023.
  • UBS O'Connor's portfolio value fell 22% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.